HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trumbo, P. R Articles by Ellwood, K. C Search for Related Content PubMed PubMed Citation Articles by Trumbo, P. R Articles by Ellwood, K. C Agricola Articles by Trumbo, P. R Articles by Ellwood, K. C

Lutein and zeaxanthin intakes and risk of age-related macular degeneration and cataracts: an evaluation using the Food and Drug Administration's evidence-based review system for health claims^1,2,3

¹ From the Division of Nutrition Programs and Labeling, Food and Drug Administration, College Park, MD

The labeling of health claims that meet the significant scientific agreement standard and of qualified health claims on conventional foods and dietary supplements requires premarket approval by the Food and Drug Administration (FDA). The FDA conducts an evidence-based review to ascertain whether sufficient evidence exists to support a significant scientific agreement standard or a qualified health claim. The FDA recently reviewed intervention and observational studies that evaluated the role of lutein and zeaxanthin in reducing the risk of age-related macular degeneration and cataracts. On the basis of this evidence-based review, the FDA concluded that no credible evidence exists for a health claim about the intake of lutein or zeaxanthin (or both) and the risk of age-related macular degeneration or cataracts.

Key Words: Lutein • zeaxanthin • age-related macular degeneration • cataracts • health claims

This article has been cited by other articles:

				L. Zhao and B. V. Sweet Lutein and zeaxanthin for macular degeneration Am. J. Health Syst. Pharm., July 1, 2008; 65(13): 1232 - 1238. [Abstract] [Full Text] [PDF]